| Open Document File Size: 729,36 KBShare Result on Facebook
Company Axcentive SARL / B. Sponsor Axcentive SARL / Principal Roz Schnick Consulting LLC / / Event FDA Phase / / IndustryTerm treatment for clinical signs of the disease / treatment of external columnaris disease / topical site / brain heart infusion media / / MedicalCondition external columnaris disease / disease / bacterial gill disease / / Organization Food Safety / Upper Midwest Environmental Sciences Center / United States Department of the Interior / U.S. Fish and Wildlife Service / / Person David Oviedo / Larry Telles / Bob David / James D. Bowker / Jeffrey J. Rach / / Position Investigator / MT Study Investigator / Director / / Product apache / Animal Drug / /
SocialTag |
Date of Approval: April 30, 2014 FREEDOM OF INFORMATION SUMMARY ORIGINAL NEW ANIMAL DRUG APPLICATION NADA[removed]